These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31373579)

  • 21. Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.
    Göçmen AY; Gümüşlü S; Semiz E
    Clin Cardiol; 2004 Jul; 27(7):426-30. PubMed ID: 15298047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased ApoB/ApoA1 ratio is associated with excess weight, body adiposity, and altered lipid profile in children.
    Castro APP; Hermsdorff HHM; Milagres LC; Albuquerque FM; Filgueiras MS; Rocha NP; Novaes JF
    J Pediatr (Rio J); 2019; 95(2):238-246. PubMed ID: 29438687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio.
    Kappelle PJ; Gansevoort RT; Hillege HJ; Wolffenbuttel BH; Dullaart RP;
    J Clin Lipidol; 2013; 7(1):56-64. PubMed ID: 23351584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reference intervals for six lipid analytes in 8-14 year-old school children from three different ethnical groups in the Hulun Buir area of China.
    Du Y; Sun H; Li Y; Shi X; Pei D; Qi D; Wang B
    Clin Lab; 2014; 60(8):1295-300. PubMed ID: 25185414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contents of apolipoprotein A-I, A-II and B of the human serum fractions for high-density and low-density lipoproteins prepared by common precipitation methods.
    Väisänen S; Gävert J; Julkunen A; Voutilainen E; Penttilä I
    Scand J Clin Lab Invest; 1992 Dec; 52(8):853-62. PubMed ID: 1488623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in cardiovascular risk factors and inflammatory markers of young, healthy, men after six weeks of moderate or high intensity resistance training.
    Sheikholeslami Vatani D; Ahmadi S; Ahmadi Dehrashid K; Gharibi F
    J Sports Med Phys Fitness; 2011 Dec; 51(4):695-700. PubMed ID: 22212275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Congestive heart failure is associated with lipoprotein components in statin-treated patients with coronary heart disease Insights from the Incremental Decrease in End points Through Aggressive Lipid Lowering Trial (IDEAL).
    Holme I; Strandberg TE; Faergeman O; Kastelein JJ; Olsson AG; Tikkanen MJ; Larsen ML; Lindahl C; Pedersen TR;
    Atherosclerosis; 2009 Aug; 205(2):522-7. PubMed ID: 19327776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ApoB-100 and ApoB/ApoA-1 ratio in children and adolescents from families with very early myocardial infarction.
    Dirisamer A; Stadler A; Bucek RA; Widhalm K
    Acta Paediatr; 2006 Jul; 95(7):810-3. PubMed ID: 16801176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ApoB/ApoA1 ratio and non-HDL-cholesterol/HDL-cholesterol ratio are associated to metabolic syndrome in patients with type 2 diabetes mellitus subjects and to ischemic cardiomyopathy in diabetic women.
    Reynoso-Villalpando GL; Sevillano-Collantes C; Valle Y; Moreno-Ruiz I; Padilla-Gutiérrez JR; Del Cañizo-Gómez FJ
    Endocrinol Diabetes Nutr (Engl Ed); 2019 Oct; 66(8):502-511. PubMed ID: 31182348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects on lipid and apolipoprotein serum levels of long-term carbamazepine, valproic acid and phenobarbital therapy in children with epilepsy.
    Eirís J; Novo-Rodríguez MI; Del Río M; Meseguer P; Del Río MC; Castro-Gago M
    Epilepsy Res; 2000 Aug; 41(1):1-7. PubMed ID: 10924863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations of apolipoprotein B/apolipoprotein A-I ratio with pre-diabetes and diabetes risks: a cross-sectional study in Chinese adults.
    Zheng S; Han T; Xu H; Zhou H; Ren X; Wu P; Zheng J; Wang L; Zhang M; Jiang Y; Chen Y; Qiu H; Liu W; Hu Y
    BMJ Open; 2017 Jan; 7(1):e014038. PubMed ID: 28110289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of age on the association of non-high-density-lipoprotein cholesterol and apolipoprotein B with cardiovascular mortality in a Mediterranean population with type 2 diabetes: the Casale Monferrato study.
    Bruno G; Merletti F; Biggeri A; Bargero G; Prina-Cerai S; Pagano G; Cavallo-Perin P
    Diabetologia; 2006 May; 49(5):937-44. PubMed ID: 16525840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of dietary fats and cholesterol on liver lipid content and hepatic apolipoprotein A-I, B, and E and LDL receptor mRNA levels in cebus monkeys.
    Hennessy LK; Osada J; Ordovas JM; Nicolosi RJ; Stucchi AF; Brousseau ME; Schaefer EJ
    J Lipid Res; 1992 Mar; 33(3):351-60. PubMed ID: 1314879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ApoB but not LDL-cholesterol is reduced by exercise training in overweight healthy men. Results from the 1-year randomized Oslo Diet and Exercise Study.
    Holme I; Høstmark AT; Anderssen SA
    J Intern Med; 2007 Aug; 262(2):235-43. PubMed ID: 17645591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study.
    Walldius G; Jungner I; Holme I; Aastveit AH; Kolar W; Steiner E
    Lancet; 2001 Dec; 358(9298):2026-33. PubMed ID: 11755609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
    Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
    Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum apolipoproteins A-I and B as markers of coronary artery disease risk in early life: the Bogalusa Heart Study.
    Srinivasan SR; Berenson GS
    Clin Chem; 1995 Jan; 41(1):159-64. PubMed ID: 7813072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macrovascular disease is associated with increased plasma apolipoprotein A-IV levels in NIDDM.
    Vergès BL; Lagrost L; Vaillant G; Petit JM; Cohen M; Gambert P; Brun JM
    Diabetes; 1997 Jan; 46(1):125-32. PubMed ID: 8971092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular risk factors in obese children in relation to weight and body fat distribution.
    Zwiauer KF; Pakosta R; Mueller T; Widhalm K
    J Am Coll Nutr; 1992 Jun; 11 Suppl():41S-50S. PubMed ID: 1619199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased serum levels of interleukin-1beta in the systemic circulation of patients with essential hypertension: additional risk factor for atherogenesis in hypertensive patients?
    Dalekos GN; Elisaf M; Bairaktari E; Tsolas O; Siamopoulos KC
    J Lab Clin Med; 1997 Mar; 129(3):300-8. PubMed ID: 9042815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.